CNO Financial Group, Inc.: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Aug 9, 2023 and accepted by EDGAR at Aug 9, 2023, 16:23 ET.
Management's discussion and analysis
As filed, 104,519 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In this section, we review the consolidated financial condition of CNO at June 30, 2023, and its consolidated results of operations for the six months ended June 30, 2023 and 2022, and, where appropriate, factors that may affect future financial performance. Please read this discussion in conjunction with the accompanying consolidated financial statements and notes. Results for interim periods are not necessarily indicative of the results that may be expected for a full year.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Our statements, trend analyses and other information contained in this report and elsewhere (such as in filings by CNO with the SEC, press releases, presentations by CNO or its management or oral statements) relative to markets for CNO's products and trends in CNO's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Forward-looking statements typically are identified by the use of terms such as "anticipate," "believe," "plan," "estimate," "expect," "project," "intend," "may," "will," "would," "contemplate," "possible," "attempt," "seek," "should," "could," "goal," "target," "on track," "comfortable with," "optimistic," "guidance," "outlook" and similar words, although some forward-looking statements are expressed differently. You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other "forward-looking" information based on currently available information. The "Risk Factors" section of our 2022 Annual Report on Form 10-K provides examples of risks, uncertainties and events that could cause our actual results to differ materially from the expectations expressed in our forward-looking statements. Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things:
- general economic, market and political conditions and uncertainties, including the performance and fluctuations of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so;
- the impact of pandemics and major public health issues, including the novel coronavirus pandemic and the resulting financial market, economic and other impacts;
- exposure to interest rate risk, including interest rate volatility, may negatively impact our results of operations, financial position or cash flow;
- future investment results, including the impact of realized losses (including other-than-temporary impairment charges) may diminish the value of our invested assets and negatively impact our profitability, our financial condition and our liquidity;
- the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject;
- our ability to make anticipated changes to certain non-guaranteed elements of our life insurance products;
- our ability to obtain adequate and timely rate increases on our health products, including our long-term care business;
- the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries;
- mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates, changes in the health care market and other factors which may affect the profitability of our insurance products;
- changes in our assumptions related to deferred acquisition costs or the present value of future profits;
- the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value;
- our assumption that the positions we take on our tax return filings will not be successfully challenged by the Internal Revenue Service;
- changes in accounting principles and the interpretation thereof;
- our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements;
- performance and valuation of our investments;
- our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition;
- our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs;
- changes in capital deployment opportunities;
- our ability to maintain effective controls over financial reporting and modeling;
- our ability to continue to recruit and retain productive agents and distribution partners;
- customer response to new products, distribution channels and marketing initiatives;
- inflation or other unfavorable economic or business conditions may impact the sales and persistency of insurance products, a portion of our insurance policy benefits affected by increased medical coverage costs and various selling, general and administrative expenses;
- our ability to maintain the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital, and the cost of capital;
- regulatory changes or actions, including: those relating to regulation of the financial affairs of our insurance companies, such as the calculation of risk-based capital and minimum capital requirements, and payment of dividends and surplus debenture interest to us; regulation of the sale, underwriting and pricing of products; health care regulation affecting health insurance products; and privacy laws and regulations;
- changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets;
- availability and effectiveness of reinsurance arrangements, as well as the impact of any defaults or failure of reinsurers to perform;
- the performance of third party service providers (both domestic and international) and potential difficulties arising from outsourcing arrangements;
- expectations for the growth rate of sales, collected premiums, annuity deposits and assets;
- interruption in telecommunication, information technology or other operational systems or failure to maintain the security, confidentiality or privacy of sensitive data on such systems;
- events of terrorism, natural disasters or other catastrophic events, including potential adverse impacts from climate change which may increase the frequency or severity of weather-related disasters;
- cyber-security attacks, risk of data loss and other security breaches;
- ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks; and
- the risk factors or uncertainties listed from time to time in our filings with the SEC.
Other factors and assumptions not identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ materially from those projected.
All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the foregoing cautionary statement. Our forward-looking statements speak only as of the date made. We assume no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.
The reporting of risk-based capital ("RBC") measures is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.
OVERVIEW
We are a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products. We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets. We sell our products through exclusive agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.
We view our operations as three insurance product lines (annuity, health and life) and the investment and fee income segments. Our segments are aligned based on their common characteristics, comparability of profit margins and the way management makes operating decisions and assesses the performance of the business.
Our insurance product line segments (annuity, health and life) include marketing, underwriting and administration of the policies our insurance subsidiaries sell. The business written in each of the three product categories through all of our insurance subsidiaries is aggregated allowing management and investors to assess the performance of each product category. Insurance product margin is management’s measure of the profitability of its annuity, health and life product lines' performance and consists of insurance policy income plus allocated investment income less insurance policy benefits, interest credited, commissions, advertising expense and amortization of acquisition costs. Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of the results of our insurance product lines.
We market our products through the Consumer and Worksite Divisions that reflect the customers served by the Company.
The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. This structure unifies consumer capabilities into a single division and integrates the strength of our agent sales forces with one of the largest direct-to-consumer insurance businesses with proven experience in advertising, web/digital and call center support.
The Worksite Division focuses on worksite and group sales for businesses, associations, and other membership groups, interacting with customers at their place of employment and virtually. With a separate Worksite Division, we are bringing a sharper focus to this high-growth business while further capitalizing on the strength of our wholly-owned subsidiary, Optavise, a national provider of year-round technology-driven employee benefits management services.
The Consumer and Worksite Divisions are primarily focused on marketing insurance products, several types of which are sold in both divisions and underwritten in the same manner. Sales of group underwritten policies are currently not significant, but are expected to increase within the Worksite Division.
The investment segment involves the management of our capital resources, including investments and the management of corporate debt and liquidity. Our measure of profitability of this segment is the total net investment income not allocated to the insurance products. Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable and investment borrowings; (iv) expenses related to the FABN program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders. Investment income not allocated to product lines includes investment income on investments in excess of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our FHLB investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from COLI and alternative investment income not allocated to product lines), net of interest expense on corporate debt. The spread earned from our FHLB investment borrowing and FABN programs includes the investment income on the matched assets less: (i) interest on investment borrowings related to the FHLB investment borrowing program; (ii) interest credited on funding agreements; and (iii) amortization of deferred acquisition costs related to the FABN program.
Our fee income segment includes the earnings generated from sales of third-party insurance products, services provided by Optavise and the operations of our broker/dealer and registered investment advisor.
Expenses not allocated to product lines include the expenses of our corporate operations, excluding interest expense on debt.
The following summarizes our earnings for the three and six months ending June 30, 2023 and 2022 (dollars in millions, except per share data):
| Insurance product margin | Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 |
|---|---|---|---|---|
| Annuity margin | $57.1 | $60.1 | $114.4 | $116.0 |
| Health margin | 108.2 | 125.4 | 224.7 | 240.7 |
| Life margin | 57.9 | 70.2 | 105.3 | 106.2 |
| Total insurance product margin | 223.2 | 255.7 | 444.4 | 462.9 |
| Allocated expenses | (149.5) | (152.2) | (307.0) | (297.0) |
| Income from insurance products | 73.7 | 103.5 | 137.4 | 165.9 |
| Fee income | .6 | 3.2 | 16.1 | 13.1 |
| Investment income not allocated to product lines | 28.0 | 64.6 | 43.5 | 91.6 |
| Expenses not allocated to product lines | (21.1) | 2.9 | (39.4) | (11.9) |
| Operating earnings before taxes | 81.2 | 174.2 | 157.6 | 258.7 |
| Income tax expense on operating income | (18.9) | (39.1) | (36.7) | (59.1) |
| Net operating income (a) | 62.3 | 135.1 | 120.9 | 199.6 |
| Net realized investment losses from sales and change in allowance for credit losses | (31.3) | (27.1) | (44.0) | (34.3) |
| Net change in market value of investments recognized in earnings | (4.0) | (21.7) | (5.9) | (47.2) |
| Fair value changes related to agent deferred compensation plan | — | 14.0 | — | 36.7 |
| Changes in fair value of embedded derivative liabilities and market risk benefits | 50.4 | 160.6 | (14.7) | 326.0 |
| Other | (.2) | (.2) | 2.1 | .2 |
| Net non-operating income (loss) before taxes | 14.9 | 125.6 | (62.5) | 281.4 |
| Income tax (expense) benefit on non-operating income (loss) | (3.5) | (27.4) | 14.5 | (64.3) |
| Net non-operating income (loss) | 11.4 | 98.2 | (48.0) | 217.1 |
| Net income | $73.7 | $233.3 | $72.9 | $416.7 |
| Per diluted share | ||||
| Net operating income | $.54 | $1.15 | $1.04 | $1.68 |
| Net non-operating income (loss) | .10 | .84 | (.41) | 1.82 |
| Net income | $.64 | $1.99 | $.63 | $3.50 |
80
(a) Management believes that an analysis of net income applicable to common stock before: (i) net realized investment gains or losses from sales, impairments and change in allowance for credit losses, net of taxes; (ii) net change in market value of investments recognized in earnings, net of taxes; (iii) changes in fair value of embedded derivative liabilities and MRBs related to our fixed indexed annuities, net of taxes; (iv) fair value changes related to the agent deferred compensation plan, net of taxes; (v) loss related to reinsurance transaction, net of taxes; (vi) loss on extinguishment of debt, net of taxes; (vii) changes in the valuation allowance for deferred tax assets and other tax items; and (viii) other non-operating items consisting primarily of earnings attributable to VIEs, net of taxes ("net operating income," a non-GAAP financial measure) is important to evaluate the financial performance of the company, and is a key measure commonly used in the life insurance industry. Management uses this measure to evaluate performance because the items excluded from net operating income can be affected by events that are unrelated to the Company's underlying fundamentals. The table above reconciles the non-GAAP measure to the corresponding GAAP measure.
In addition, management uses these non-GAAP financial measures in its budgeting process, financial analysis of segment performance and in assessing the allocation of resources. We believe these non-GAAP financial measures enhance an investor's understanding of our financial performance and allows them to make more informed judgments about the Company as a whole. These measures also highlight operating trends that might not otherwise be apparent. However, net operating income is not a measurement of financial performance under GAAP and should not be considered as an alternative to cash flow from operating activities, as measures of liquidity, or as an alternative to net income as measures of our operating performance or any other measures of performance derived in accordance with GAAP. In addition, net operating income should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Net operating income has limitations as an analytical tool, and you should not consider such measure either in isolation or as a substitute for analyzing our results as reported under GAAP. Our definition and calculation of net operating income are not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation. Also, as we adopted the new accounting standard related to targeted improvements to the accounting for long-duration insurance contracts effective January 1, 2023, we updated our method of determining non-operating earnings for our fixed indexed annuities to better identify the volatile non-economic impacts of that line of business. This resulted in fixed indexed annuity margins that more closely reflect the economics of the business.
GOVERNMENTAL REGULATION
Privacy and Cybersecurity Regulation
In July 2023, the SEC adopted the Risk Management, Strategy, Governance, and Incident Disclosure Final Rule (the "Cybersecurity Final Rule") requiring enhanced disclosures of material cybersecurity incidents in a Form 8-K and periodic disclosures of, among other things, details on the processes to assess, identify, and manage those risks, cybersecurity governance, and management's role in overseeing such a compliance program, including the board of directors' oversight of cybersecurity risks. Certain reporting requirements under the Cybersecurity Final Rule become effective as early as December 2023.
CRITICAL ACCOUNTING ESTIMATES
The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of various assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Management has made estimates in the past that we believed to be appropriate but were subsequently revised to reflect actual experience. If our future experience differs materially from these estimates and assumptions, our results of operations and financial condition could be materially affected.
Effective January 1, 2023, we adopted ASU 2018-12. The adoption of ASU 2018-12 impacted the accounting and presentation related to long-duration insurance contracts and certain related balances for the years ended December 31, 2022 and 2021. Disclosures of the impacts of ASU 2018-12 as of the Transition Date are included within the tables in the note to the consolidated financial statements entitled "Recently Adopted Accounting Standards." For a discussion of our significant accounting policies impacted by the adoption of ASU 2018-12, see the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies".
The critical accounting estimates that were not impacted as a result of the adoption of ASU 2018-12 are described in "Critical Accounting Estimates" in our 2022 Annual Report on Form 10-K. Below is a discussion of our updated critical accounting estimates.
Present Value of Future Profits and Deferred Acquisition Costs
Amortization of the present value of future profits and deferred acquisition costs is calculated using the same contract groupings (or cohorts), mortality and lapse assumptions that are used in calculating the liability for future policy benefits, and these assumptions are reviewed and updated at least annually.
As a result of the adoption of ASU 2018-12, the amortization methodology related to these account balances is no longer subject to the same degree of variability and does not require a high degree of judgment. However, these accounts remain sensitive to unexpected lapses, due to higher mortality and lapse experience than expected. Such changes are recognized in the current period as a reduction of the capitalized balances. The effect of changes in assumptions related to future mortality and lapses are recognized prospectively over the remaining contract term. The carrying value of deferred acquisition costs is not subject to recovery testing upon the adoption of ASU 2018-12.
Liabilities for Insurance Products
The adoption of ASU 2018-12 significantly changes how we account for the liabilities for insurance products for long-duration contracts and amends existing recognition, measurement, presentation and disclosure requirements. As part of this adoption, we measure all payments under an insurance contract including future expected claims and unpaid policy claims (with the exception of life insurance policy and contract claims, which are classified in the "liability for life insurance policy claims") and related expenses as an integrated reserve. This resulted in unpaid claims on long-duration health insurance contracts that were previously in the "liability for policy and contract claims" pre-adoption to be now presented as part of the liability for future policy benefits.
Our liabilities for future policy benefits are measured using the net premium ratio approach as described in the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies".
The liability for future policy benefits is determined based on numerous assumptions. The most significant assumptions for our life and annuity business are mortality and lapse/withdrawal rates which are based on our experience and, in cases of limited experience, industry experience. Mortality and lapse/withdrawal rates also take into consideration future expectations in policyholder behavior that may vary from past experience. For our health business, mortality rates, lapse rates, morbidity assumptions and future rate increases are based on our experience and, in cases of limited experience, industry experience. Such assumptions also consider future expectations in policyholder behavior that may vary from past experience. In addition, the liability for future policy benefits is measured using estimated discount rates. The assumptions and estimates that we use often depend on judgment regarding the likelihood of future events and are inherently uncertain.
Cash flow assumptions related to our insurance contracts are established when a policy is issued and are evaluated each quarter to determine if assumption updates are required. A more detailed review of assumptions is performed annually during the fourth quarter. Changes to our cash flow assumptions are recognized in the liability for future policy benefits remeasurement (gain) loss in the consolidated statement of operations. Actual experience is reflected in the calculation of future policy benefits each quarter, and changes in the liability due to actual experience are also recognized in the liability for future policy benefits remeasurement (gain) loss in the consolidated statement of operations.
Discount rates used to calculate net premiums are locked in at policy inception and provide the basis to recognize interest expense in the consolidated statement of operations. Discount rates used to measure the carrying value of the liability for future policy benefits in the consolidated balance sheet are updated each reporting period, and differences between the liability balances calculated using the locked-in rate and the updated discount rates are recognized in accumulated other comprehensive income (loss). For additional discussion on the determination of discount rates, see the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies".
Market risk benefits
MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Many of our fixed indexed annuity products include a GLWB that is considered a MRB. MRBs are measured at fair value using an option-based valuation model based on amount of exposure, market data, Company experience and other factors. Changes in fair value are recognized in earnings each period with the exception of the portion of the change in fair value due to a change in the instrument-specific credit risk, which is recognized in accumulated other comprehensive income (loss). MRBs in an asset position are presented separately from those in a liability position as there is no legal right of offset between contracts.
The cost of MRBs may rise in volatile or declining equity markets or in a low interest rate environment. Market conditions including, but not limited to, changes in interest rates, equity indices, market volatility, variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could affect net income and changes in our nonperformance risk could materially affect other comprehensive income.
RESULTS OF OPERATIONS
The following tables and narratives summarize the operating results of our segments (dollars in millions):
| Insurance product margin Annuity: | Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 |
|---|---|---|---|---|
| Insurance policy income | $8.1 | $5.8 | $13.2 | $10.8 |
| Net investment income | 127.7 | 117.8 | 253.1 | 235.3 |
| Insurance policy benefits | (10.6) | (6.8) | (19.3) | (16.3) |
| Interest credited | (50.6) | (41.4) | (98.7) | (83.9) |
| Amortization and non-deferred commissions | (17.5) | (15.3) | (33.9) | (29.9) |
| Annuity margin | 57.1 | 60.1 | 114.4 | 116.0 |
| Health: | ||||
| Insurance policy income | 397.1 | 403.5 | 798.5 | 810.2 |
| Net investment income | 74.3 | 73.0 | 148.3 | 146.3 |
| Insurance policy benefits | (322.7) | (309.9) | (640.8) | (633.0) |
| Amortization and non-deferred commissions | (40.5) | (41.2) | (81.3) | (82.8) |
| Health margin | 108.2 | 125.4 | 224.7 | 240.7 |
| Life: | ||||
| Insurance policy income | 223.1 | 216.3 | 442.1 | 429.6 |
| Net investment income | 36.1 | 35.2 | 72.4 | 70.7 |
| Insurance policy benefits | (142.8) | (127.7) | (290.0) | (280.8) |
| Interest credited | (12.2) | (11.7) | (24.3) | (23.7) |
| Amortization and non-deferred commissions | (20.8) | (19.3) | (40.7) | (37.7) |
| Advertising expense | (25.5) | (22.6) | (54.2) | (51.9) |
| Life margin | 57.9 | 70.2 | 105.3 | 106.2 |
| Total insurance product margin | 223.2 | 255.7 | 444.4 | 462.9 |
| Allocated expenses: | ||||
| Branch office expenses | (15.9) | (15.4) | (35.7) | (33.5) |
| Other allocated expenses | (133.6) | (136.8) | (271.3) | (263.5) |
| Income from insurance products | 73.7 | 103.5 | 137.4 | 165.9 |
| Fee income | .6 | 3.2 | 16.1 | 13.1 |
| Investment income not allocated to product lines | 28.0 | 64.6 | 43.5 | 91.6 |
| Expenses not allocated to product lines | (21.1) | 2.9 | (39.4) | (11.9) |
| Operating earnings before taxes | 81.2 | 174.2 | 157.6 | 258.7 |
| Income tax expense on operating income | (18.9) | (39.1) | (36.7) | (59.1) |
| Net operating income | $62.3 | $135.1 | $120.9 | $199.6 |
CNO is the top tier holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products. We view our operations by segments, which consist of insurance product lines. These products are distributed by our two divisions. The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. The Worksite Division focuses on worksite and group sales for businesses, associations, and other membership groups, interacting with customers at their place of employment and virtually.
Insurance product margin is management’s measure of the profitability of its annuity, health and life product lines' performance and consists of insurance policy income plus allocated investment income less insurance policy benefits, interest credited, commissions, advertising expense and amortization of acquisition costs. Income from insurance products is the sum of the insurance margins of the annuity, health and life product lines, less expenses allocated to the insurance lines. It excludes the income from our fee income business, investment income not allocated to product lines, net expenses not allocated to product lines (primarily holding company expenses) and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of the results of our insurance product lines.
Net investment income is allocated to the product lines using the book yield of investments backing the block of business, which is applied to the average net insurance liabilities for the block in each period. Net insurance liabilities for the purpose of allocating investment income to product lines are equal to: (i) policyholder account balances for annuity products; (ii) total reserves before the fair value adjustments reflected in accumulated other comprehensive income (loss), if applicable, for all other products; less (iii) amounts related to reinsurance business; (iv) deferred acquisition costs; (v) the present value of future profits; and (vi) the value of unexpired options credited to insurance liabilities. Investment income not allocated to product lines represents net investment income less: (i) equity returns credited to policyholder account balances; (ii) the investment income allocated to our product lines; (iii) interest expense on notes payable and investment borrowings; (iv) expenses related to the FABN program; and (v) certain expenses related to benefit plans that are offset by special-purpose investment income; plus (vi) the impact of annual option forfeitures related to fixed indexed annuity surrenders. Investment income not allocated to product lines includes investment income on investments in excess of amounts allocated to product lines, investments held by our holding companies, the spread we earn from our FHLB investment borrowing and FABN programs and variable components of investment income (including call and prepayment income, adjustments to returns on structured securities due to cash flow changes, income (loss) from COLI and alternative investment income not allocated to product lines), net of interest expense on corporate debt.
Summary of Operating Results: Net operating income was $62.3 million in the second quarter of 2023, down from $135.1 million in the second quarter of 2022, and was $120.9 million in the first six months of 2023, down from $199.6 million in the first six months of 2022.
Insurance product margin was $223.2 million in the second quarter of 2023 compared to $255.7 million in the second quarter of 2022, and was $444.4 million in the first six months of 2023 compared to $462.9 million in the first six months of 2022. Insurance product margins in the 2023 periods were impacted by unfavorable claim experience in our Medicare supplement and long-term care lines of business. In addition, the traditional life margin was favorably impacted in the second quarter of 2022 due to a larger than typical reduction in claim liabilities due to the work down of a backlog of claims that were in-the-course-of-settlement. Such claim payments also had a positive impact (of approximately $10 million) on the change in the liability for future policy benefits as calculated under the new LDTI standard.
Total allocated and unallocated expenses are summarized in the table below. Expenses not allocated to product lines in the second quarter of 2022 include the impact of a significant item related to an experience refund pursuant to the terms of a reinsurance agreement. Total allocated and unallocated expenses as adjusted for the significant item are summarized below (dollars in millions):
| Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 | |
|---|---|---|---|---|
| Expenses allocated to product lines | $149.5 | $152.2 | $307.0 | $297.0 |
| Expenses not allocated to product lines | 21.1 | (2.9) | 39.4 | 11.9 |
| Experience refund related to a reinsurance agreement (a) | — | 22.5 | — | 22.5 |
| Adjusted total | $170.6 | $171.8 | $346.4 | $331.4 |
(a) Under the terms of the reinsurance agreement to cede a substantial portion of our legacy long-term care block, we were entitled to receive an experience refund of up to $22.5 million if certain rate increases were approved and implemented. As of June 30, 2022, all requirements to earn the maximum experience refund had been met and the refund was recognized. The refund was received in the second quarter of 2023.
Though expenses were elevated in the first six months of 2023, our projected expense ratio for the full year of between 19.0 percent to 19.4 percent remains unchanged. The expense ratio is defined as total allocated and unallocated expenses (excluding any significant items) divided by the sum of insurance policy income and net investment income allocated to products.
The fee income segment is summarized below (dollars in millions):
| Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 | |
|---|---|---|---|---|
| Fee revenue | $29.4 | $31.1 | $80.7 | $71.4 |
| Operating costs and expenses | (28.8) | (27.9) | (64.6) | (58.3) |
| Net fee income | $.6 | $3.2 | $16.1 | $13.1 |
The increase in net fee income in the first six months of 2023 is due to growth in the sales of third party products in recent periods and changes to our revenue recognition assumptions reflecting favorable policy persistency, partially offset by lower net fee income related to services provided by Optavise. The decrease in net fee income in the second quarter of 2023, as compared to the same period in 2022, reflects less favorable changes to our revenue recognition assumptions on the sales of third party products and higher expenses incurred by Optavise.
Investment income not allocated to product lines generally fluctuates from period to period based on the level of prepayment income (including call premiums) and trading account income; the performance of our alternative investments (which are typically reported a quarter in arrears); the earnings related to the investments underlying our COLI; and the spread we earn from our FHLB investment borrowing and FABN programs.
The effective tax rate for the first six months of 2023 was 23.3 percent which was consistent with our expected annual effective tax rate for 2023 of between 23 percent and 24 percent.
Margin from Annuity Products (dollars in millions):
| Annuity margin: Fixed indexed annuities | Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 |
|---|---|---|---|---|
| Insurance policy income | $5.5 | $3.7 | $9.1 | $6.7 |
| Net investment income | 101.2 | 91.4 | 200.0 | 181.5 |
| Insurance policy benefits | (4.2) | (3.1) | (8.3) | (7.7) |
| Interest credited | (38.9) | (29.5) | (75.3) | (59.9) |
| Amortization and non-deferred commissions | (16.0) | (14.1) | (31.4) | (27.4) |
| Margin from fixed indexed annuities | $47.6 | $48.4 | $94.1 | $93.2 |
| Average net insurance liabilities | $9,276.0 | $8,711.0 | $9,229.9 | $8,598.7 |
| Margin/average net insurance liabilities | 2.05% | 2.22% | 2.04% | 2.17% |
| Fixed interest annuities | ||||
| Insurance policy income | $.2 | $.3 | $.5 | $.4 |
| Net investment income | 20.9 | 20.6 | 41.8 | 42.1 |
| Insurance policy benefits | — | (.6) | (.1) | (1.0) |
| Interest credited | (11.1) | (11.3) | (22.2) | (22.8) |
| Amortization and non-deferred commissions | (1.3) | (1.1) | (2.2) | (2.3) |
| Margin from fixed interest annuities | $8.7 | $7.9 | $17.8 | $16.4 |
| Average net insurance liabilities | $1,613.1 | $1,712.5 | $1,622.0 | $1,736.8 |
| Margin/average net insurance liabilities | 2.16% | 1.85% | 2.19% | 1.89% |
| Other annuities | ||||
| Insurance policy income | $2.4 | $1.8 | $3.6 | $3.7 |
| Net investment income | 5.6 | 5.8 | 11.3 | 11.7 |
| Insurance policy benefits | (6.4) | (3.1) | (10.9) | (7.6) |
| Interest credited | (.6) | (.6) | (1.2) | (1.2) |
| Amortization and non-deferred commissions | (.2) | (.1) | (.3) | (.2) |
| Margin from other annuities | $.8 | $3.8 | $2.5 | $6.4 |
| Average net insurance liabilities | $462.5 | $484.2 | $466.0 | $487.2 |
| Margin/average net insurance liabilities | .69% | 3.14% | 1.07% | 2.63% |
| Total annuity margin | $57.1 | $60.1 | $114.4 | $116.0 |
| Average net insurance liabilities | $11,351.6 | $10,907.7 | $11,317.9 | $10,822.7 |
| Margin/average net insurance liabilities | 2.01% | 2.20% | 2.02% | 2.14% |
Margin from fixed indexed annuities was $47.6 million in the second quarter of 2023 compared to $48.4 million in the second quarter of 2022, and was $94.1 million in the first six months of 2023 compared to $93.2 million in the first six months of 2022. The margins in 2023 are relatively flat, as compared to the same periods in the prior year, as growth in the block is primarily being offset by spread compression driven by increased surrenders of higher spread products. Average net insurance liabilities (policyholder account balances less: (i) amounts related to reinsured business; (ii) deferred acquisition costs; (iii) present value of future profits; and (iv) the value of unexpired options credited to insurance liabilities) were $9,276.0 million and $8,711.0 million in the second quarters of 2023 and 2022, respectively, and were $9,229.9 million and $8,598.7 million in the first six months of 2023 and 2022, respectively, driven by deposits and reinvested returns in excess of withdrawals. The increase in net insurance liabilities results in higher net investment income allocated. The earned yield was 4.36 percent in the second quarter of 2023 up from 4.20 percent in the second quarter of 2022, and was 4.33 percent in the first six months of 2023 up from 4.22 percent in the first six months of 2022, reflecting higher portfolio yields.
Net investment income and interest credited exclude the change in market values of the underlying options supporting the fixed indexed annuity products and corresponding offsetting amount credited to policyholder account balances. Such amounts were $56.1 million and $(80.1) million in the second quarters of 2023 and 2022, respectively, and were $72.6 million and $(144.4) million in the first six months of 2023 and 2022, respectively.
Margin from fixed interest annuities was $8.7 million in the second quarter of 2023 compared to $7.9 million in the second quarter of 2022, and was $17.8 million in the first six months of 2023 compared to $16.4 million in the first six months of 2022, driven primarily by higher investment yields, partially offset by a reduction in the size of the block. Average net insurance liabilities were $1,613.1 million in the second quarter of 2023 compared to $1,712.5 million in the second quarter of 2022, and were $1,622.0 million in the first six months of 2023 compared to $1,736.8 million in the first six months of 2022, driven by withdrawals in excess of deposits and reinvested returns. The decrease in net insurance liabilities results in lower net investment income allocated, however, the earned yield increased to 5.18 percent in the second quarter of 2023 from 4.81 percent in the second quarter of 2022, and to 5.15 percent in the first six months of 2023 from 4.85 percent in the first six months of 2022, reflecting higher portfolio yields.
Margin from other annuities was $0.8 million in the second quarter of 2023 compared to $3.8 million in the second quarter of 2022, and was $2.5 million in the first six months of 2023 compared to $6.4 million in the first six months of 2022. The margin on this relatively small block of business is sensitive to annuitant mortality related to contracts with life contingencies. An increase in mortality in this block will result in a decrease in insurance liabilities and insurance policy benefits. Such mortality was lower in the 2023 periods compared to the same periods in 2022.
Margin from Health Products (dollars in millions):
| Health margin: Supplemental health | Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 |
|---|---|---|---|---|
| Insurance policy income | $176.2 | $172.0 | $355.2 | $345.5 |
| Net investment income | 38.9 | 37.6 | 77.5 | 75.0 |
| Insurance policy benefits | (128.9) | (128.1) | (257.1) | (257.4) |
| Amortization and non-deferred commissions | (26.3) | (25.5) | (52.4) | (51.0) |
| Margin from supplemental health | $59.9 | $56.0 | $123.2 | $112.1 |
| Margin/insurance policy income | 34% | 33% | 35% | 32% |
| Medicare supplement | ||||
| Insurance policy income | $155.3 | $165.1 | $311.8 | $331.9 |
| Net investment income | 1.2 | 1.4 | 2.5 | 2.7 |
| Insurance policy benefits | (113.4) | (114.1) | (233.9) | (234.6) |
| Amortization and non-deferred commissions | (10.8) | (12.6) | (22.0) | (25.6) |
| Margin from Medicare supplement | $32.3 | $39.8 | $58.4 | $74.4 |
| Margin/insurance policy income | 21% | 24% | 19% | 22% |
| Long-term care | ||||
| Insurance policy income | $65.6 | $66.4 | $131.5 | $132.8 |
| Net investment income | 34.2 | 34.0 | 68.3 | 68.6 |
| Insurance policy benefits | (80.4) | (67.7) | (149.8) | (141.0) |
| Amortization and non-deferred commissions | (3.4) | (3.1) | (6.9) | (6.2) |
| Margin from long-term care | $16.0 | $29.6 | $43.1 | $54.2 |
| Margin/insurance policy income | 24% | 45% | 33% | 41% |
| Total health margin | $108.2 | $125.4 | $224.7 | $240.7 |
| Margin/insurance policy income | 27% | 31% | 28% | 30% |
Margin from supplemental health business was $59.9 million in the second quarter of 2023 compared to $56.0 million in the second quarter of 2022, and was $123.2 million in the first six months of 2023 compared to $112.1 million in the first six months of 2022, reflecting growth in the block. The margin as a percentage of insurance policy income was 34 percent in the second quarter of 2023 compared to 33 percent in the prior year period, and was 35 percent in the first six months of 2023 compared to 32 percent in the first six months of 2022.
Our supplemental health products (including specified disease, accident and hospital indemnity products) generally provide fixed or limited benefits. For example, payments under cancer insurance policies are generally made directly to, or at the direction of, the policyholder following diagnosis of, or treatment for, a covered type of cancer. Approximately three-fourths of our supplemental health policies inforce (based on policy count) are sold with return of premium or cash value riders. The return of premium rider generally provides that after a policy has been inforce for a specified number of years or upon the policyholder reaching a specified age, we will pay to the policyholder, or a beneficiary under the policy, the aggregate amount of all premiums paid under the policy, without interest, less the aggregate amount of all claims incurred under the policy. The cash value rider is similar to the return of premium rider, but also provides for payment of a graded portion of the return of premium benefit if the policy terminates before the return of premium benefit is earned. Accordingly, the net cash flows from these products generally result in the accumulation of amounts in the early years of a policy (reflected in our earnings as reserve increases which is a component of insurance policy benefits) which will be paid out as benefits in later policy years (reflected in our earnings as reserve decreases which offset the recording of benefit payments). As the policies age, insurance policy benefits will typically increase, but the increase in benefits will be partially offset by investment income earned on the accumulated assets.
Margin from Medicare supplement business was $32.3 million and $39.8 million in the second quarters of 2023 and 2022, respectively, and $58.4 million and $74.4 million in the first six months of 2023 and 2022, respectively. The decrease in margin on the Medicare supplement business is primarily due to a reduction in the size of the block and unfavorable claims experience. Claim experience will fluctuate from period to period. Insurance policy income was $155.3 million in the second quarter of 2023, down 5.9 percent from the second quarter of 2022, and was $311.8 million the first six months of 2023 down 6.1 percent from the first six months of 2022, reflecting lower sales in recent periods partially offset by premium rate increases. Over the last several years, we have experienced a shift in the sale of Medicare supplement policies to the sale of Medicare Advantage policies. We receive fee income when Medicare Advantage policies of other providers are sold, which is recorded in our Fee income segment. We continue to invest in both our Medicare supplement products and Medicare Advantage distribution to meet our customers' needs and preferences. For example, we launched a new competitive Medicare supplement product in 2022.
Medicare supplement business consists of both individual and group policies. Government regulations generally require we attain and maintain a ratio of total benefits incurred to total premiums earned (excluding changes in policy benefits reserves which is a component of Insurance policy benefits) of not less than 65 percent on individual products and not less than 75 percent on group products. The ratio is determined after three years from the original issuance of the policy and over the lifetime of the policy and measured in accordance with statutory accounting principles. Since the insurance product liabilities we establish for Medicare supplement business are subject to significant estimates, the ultimate claim liability we incur for a particular period is likely to be different than our initial estimate. Changes to our estimates are reflected in insurance policy benefits in the period the change is determined.
Margin from Long-term care products was $16.0 million and $29.6 million in the second quarters of 2023 and 2022, respectively, and $43.1 million and $54.2 million in the first six months of 2023 and 2022, respectively. The margin as a percentage of insurance policy income was 24 percent in the second quarter of 2023 compared to 45 percent in the second quarter of 2022, and was 33 percent in the first six months of 2023 compared to 41 percent in the first six months of 2022. The decrease in margins in the 2023 periods is primarily due to unfavorable claims experience as compared to the prior year periods. The unfavorable experience in this block is expected to moderate in future periods, however claim experience will fluctuate from quarter to quarter.
Margin from Life Products (dollars in millions):
| Life margin: Interest-sensitive life | Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 |
|---|---|---|---|---|
| Insurance policy income | $45.3 | $43.8 | $89.8 | $86.9 |
| Net investment income | 12.7 | 12.8 | 25.8 | 25.8 |
| Insurance policy benefits | (17.1) | (15.8) | (35.3) | (37.0) |
| Interest credited | (12.0) | (11.5) | (24.0) | (23.4) |
| Amortization and non-deferred commissions | (4.8) | (5.9) | (9.4) | (11.6) |
| Margin from interest-sensitive life | $24.1 | $23.4 | $46.9 | $40.7 |
| Average net insurance liabilities | $1,035.4 | $1,016.4 | $1,033.7 | $1,012.9 |
| Interest margin | $.7 | $1.3 | $1.8 | $2.4 |
| Interest margin/average net insurance liabilities | .27% | .51% | .35% | .47% |
| Underwriting margin | $23.4 | $22.1 | $45.1 | $38.3 |
| Underwriting margin/insurance policy income | 52% | 50% | 50% | 44% |
| Traditional life | ||||
| Insurance policy income | $177.8 | $172.5 | $352.3 | $342.7 |
| Net investment income | 23.4 | 22.4 | 46.6 | 44.9 |
| Insurance policy benefits | (125.7) | (111.9) | (254.7) | (243.8) |
| Interest credited | (.2) | (.2) | (.3) | (.3) |
| Amortization and non-deferred commissions | (16.0) | (13.4) | (31.3) | (26.1) |
| Advertising expense | (25.5) | (22.6) | (54.2) | (51.9) |
| Margin from traditional life | $33.8 | $46.8 | $58.4 | $65.5 |
| Margin/insurance policy income | 19% | 27% | 17% | 19% |
| Margin excluding advertising expense/insurance policy income | 33% | 40% | 32% | 34% |
| Total life margin | $57.9 | $70.2 | $105.3 | $106.2 |
Margin from interest-sensitive life business was $24.1 million in the second quarter of 2023, up 3.0 percent from the second quarter of 2022, and was $46.9 million in the first six months of 2023, up 15 percent from the first six months of 2022, reflecting favorable mortality, as compared to the 2022 periods, and growth in the block due to sales in recent periods.
The interest margin was $0.7 million and $1.3 million in the second quarters of 2023 and 2022, respectively, and was $1.8 million and $2.4 million in the first six months of 2023 and 2022, respectively. Net investment income in the 2023 periods was comparable to the 2022 periods. The increase in average net insurance liabilities results in higher net investment income allocated, which is partially offset by lower earned yields. The earned yield was 4.91 percent and 5.04 percent in the second quarters of 2023 and 2022, respectively, and was 4.99 percent and 5.09 percent in the first six months of 2023 and 2022, respectively. The decrease in earned yields is due to the sale or maturity of higher yielding investments. Interest credited to policyholders may be changed annually but is subject to minimum guaranteed rates and, as a result, any reduction in our earned rate may not be fully reflected in the rate credited to policyholders.
Net investment income and interest credited exclude the change in market values of the underlying options supporting the fixed indexed life products and corresponding offsetting amount credited to policyholder account balances. Such amounts were $6.2 million and $(12.3) million in the second quarters of 2023 and 2022, respectively, and were $8.3 million and $(19.9) million in the first six months of 2023 and 2022, respectively.
Margin from traditional life business was $33.8 million and $46.8 million in the second quarters of 2023 and 2022, respectively, and was $58.4 million and $65.5 million in the first six months of 2023 and 2022, respectively. In the second quarter of 2022, there was a larger than typical reduction in traditional life claim liabilities due to the work down of a backlog of claims that were in-the-course-of-settlement. The claim payments also had a favorable impact (of approximately $10 million) on the change in the liability for future policy benefits, as calculated under the new LDTI standard, which is the primary driver of the decrease in the traditional life margin in the 2023 periods as compared to the same periods in 2022.
Allocated net investment income was higher in the 2023 periods, as compared to the 2022 periods, primarily due to growth in the block and higher investment yields. The earned yield was 4.74 percent and 4.59 percent in the second quarters of 2023 and 2022, respectively and was 4.72 percent and 4.60 percent in the first six months of 2023 and 2022, respectively.
Advertising expense was $25.5 million in the second quarter of 2023, up 13 percent from the comparable period in 2022, and was $54.2 million in the first six months of 2023, up 4.4 percent from the comparable period in 2022. The demand and cost of television advertising can fluctuate from period to period. We are disciplined with our marketing expenditures and will increase or decrease our marketing spend depending on the current economics of the purchase or other factors.
Collected Premiums From Annuity and Interest-Sensitive Life Products (dollars in millions):
| Collected premiums from annuity and interest-sensitive life products: | Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 |
|---|---|---|---|---|
| Annuities | $401.8 | $435.0 | $772.7 | $803.6 |
| Interest-sensitive life | 60.3 | 56.6 | 118.5 | 113.2 |
| Total collected premiums from annuity and interest-sensitive life products | $462.1 | $491.6 | $891.2 | $916.8 |
Collected premiums from annuity and interest-sensitive products decreased 6.0 percent in the second quarter of 2023 compared to the second quarter of 2022, and 2.8 percent in the first six months of 2023 compared to the first six months of 2022. Premium collections from fixed indexed annuities decreased 15 percent to $351.6 million in the second quarter of 2023 compared to the same period of 2022, and 12 percent to $674.9 million in the first six months of 2023 compared to the first six months of 2022. Premium collections from fixed interest annuities increased 121 percent to $46.6 million in the second quarter of 2023 compared to the same period in 2022, and 183 percent to $92.7 million in the first six months of 2023 compared to the first six months of 2022, resulting from increased consumer preference for these products in the current interest rate environment.
Investment Income Not Allocated to Product Lines (dollars in millions):
| Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 | |
|---|---|---|---|---|
| Net investment income | $399.7 | $223.9 | $742.7 | $432.1 |
| Allocated to product lines: | ||||
| Annuity | (127.7) | (117.8) | (253.1) | (235.3) |
| Health | (74.3) | (73.0) | (148.3) | (146.3) |
| Life | (36.1) | (35.2) | (72.4) | (70.7) |
| Equity returns credited to policyholder account balances | (62.3) | 92.4 | (80.9) | 164.3 |
| Amounts allocated to product lines and credited to policyholder account balances | (300.4) | (133.6) | (554.7) | (288.0) |
| Impact of annual option forfeitures related to fixed indexed annuity surrenders | 1.4 | (.5) | 1.4 | 1.1 |
| Amount related to variable interest entities and other non-operating items | (19.0) | (9.1) | (39.9) | (16.3) |
| Interest expense on debt | (15.6) | (15.6) | (31.3) | (31.3) |
| Interest expense on investment borrowings from FHLB | (24.2) | (4.7) | (45.9) | (7.1) |
| Expenses related to FABN program | (7.6) | (7.6) | (15.2) | (14.9) |
| Less amounts credited to deferred compensation plans (offsetting investment income) | (6.3) | 11.8 | (13.6) | 16.0 |
| Total adjustments | (71.3) | (25.7) | (144.5) | (52.5) |
| Investment income not allocated to product lines | $28.0 | $64.6 | $43.5 | $91.6 |
The above table reconciles net investment income to investment income not allocated to product lines. Such amount will generally fluctuate from period to period based on the level of prepayment income (including call premiums) and trading account income; the performance of our alternative investments (which are typically reported a quarter in arrears); the earnings related to the investments underlying our COLI; and the spread we earn from our FHLB investment borrowing and FABN programs.
Net Non-Operating Income:
The following summarizes our net non-operating income (loss) for the three and six months ending June 30, 2023 and 2022 (dollars in millions):
| Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 | |
|---|---|---|---|---|
| Net realized investment losses from sales and change in allowance for credit losses | $(31.3) | $(27.1) | $(44.0) | $(34.3) |
| Net change in market value of investments recognized in earnings | (4.0) | (21.7) | (5.9) | (47.2) |
| Fair value changes related to agent deferred compensation plan | — | 14.0 | — | 36.7 |
| Changes in fair value of embedded derivative liabilities and market risk benefits | 50.4 | 160.6 | (14.7) | 326.0 |
| Other | (.2) | (.2) | 2.1 | .2 |
| Net non-operating income (loss) before taxes | $14.9 | $125.6 | $(62.5) | $281.4 |
Net realized investment losses in the three and six months ended June 30, 2023, were $31.3 million and $44.0 million, respectively, including the unfavorable change in the allowance for credit losses of $9.9 million and $11.4 million, respectively, which was recorded in earnings. Net realized investment losses in the three and six months ended June 30, 2022, were $27.1 million and $34.3 million, respectively, including the unfavorable change in the allowance for credit losses of $23.7 million and $54.4 million, respectively, which was recorded in earnings.
The change in market value of investments recognized in earnings was a decrease of $4.0 million and $21.7 million in the second quarters of 2023 and 2022, respectively, and $5.9 million and $47.2 million in the first six months of 2023 and 2022, respectively. The change in value will fluctuate from period to period based on market conditions.
During the first six months of 2022, we recognized an increase in earnings of $36.7 million for the mark-to-market change in the agent deferred compensation plan liability which was impacted by changes in the underlying actuarial assumptions used to value the liability. We recognize the mark-to-market change in the estimated value of this liability through earnings as assumptions change.
We recognized an increase (decrease) in earnings of $(14.7) million and $326.0 million in the first six months of 2023 and 2022, respectively, resulting from changes in the fair value of embedded derivative liabilities and MRBs related to our fixed indexed annuities. Such amounts include the impacts of changes in market interest rates and equity impacts used to determine the estimated fair values of the embedded derivatives and MRBs.
Other non-operating items primarily include earnings attributable to VIEs that we are required to consolidate, net of affiliated amounts. Such earnings are not indicative of, and are unrelated to, the Company's underlying fundamentals.
LIQUIDITY AND CAPITAL RESOURCES
2023 Outlook
Prior to the sharp rise in interest rates in the United States in 2022, interest rates had been at or near historically low levels. We expect that a continued level of higher interest rates will benefit our operating results over time. We continuously monitor current market conditions and the impact to our business from potential changes in overall economic growth. We are also subject to financial impacts associated with changes in the equity markets and the credit cycle.
We are in the process of seeking approval for the formation of a wholly-owned Bermuda captive reinsurance company for the purpose of ceding a portion of our inforce fixed indexed annuity business and all of the new fixed indexed annuity business written after the inception of the reinsurance agreement. We do not anticipate assuming any unaffiliated business or seeking any third party capital for our wholly-owned Bermuda captive reinsurance company.
For 2023, we currently expect operating earnings per diluted share to be in the range of $2.65 to $2.85, excluding any significant items in the year (down from our previous guidance of $2.80 to $3.00 per diluted share). Our current guidance reflects the lower alternative investment income and elevated claims experience in our long-term care and Medicare supplement blocks of business that we recognized in the first half of 2023.
With respect to excess cash flow in 2023, we currently expect cash flow to the holding company to be in the range of $180 million to $200 million (assuming our current capital and reinsurance structure), as compared to our previous guidance of $170 million to $200 million.
Our capital structure as of June 30, 2023 and December 31, 2022 was as follows (dollars in millions):
| Total capital: | June 30, 2023 | December 31, 2022 |
|---|---|---|
| Corporate notes payable | $1,139.7 | $1,138.8 |
| Shareholders’ equity: | ||
| Common stock | 1.1 | 1.1 |
| Additional paid-in capital | 1,997.9 | 2,033.8 |
| Accumulated other comprehensive loss | (1,733.5) | (1,957.3) |
| Retained earnings | 1,730.3 | 1,691.2 |
| Total shareholders’ equity | 1,995.8 | 1,768.8 |
| Total capital | $3,135.5 | $2,907.6 |
The following table summarizes certain financial ratios as of and for the six months ended June 30, 2023 and as of and for the year ended December 31, 2022:
| June 30, 2023 | December 31, 2022 | |
|---|---|---|
| Book value per common share | $17.56 | $15.47 |
| Book value per common share, excluding accumulated other comprehensive income (loss) (a) | 32.81 | 32.59 |
| Debt to total capital ratios: | ||
| Corporate debt to total capital | 36.3% | 39.2% |
| Corporate debt to total capital, excluding accumulated other comprehensive income (loss) (a) (b) | 23.4% | 23.4% |
(a) This non-GAAP measure differs from the corresponding GAAP measure presented immediately above, because accumulated other comprehensive income (loss) has been excluded from the value of capital used to determine this measure. Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income (loss). Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management. However, this measure does not replace the corresponding GAAP measure.
(b) Our targeted ratio is in the range of 25.0 percent to 28.0 percent.
Liquidity for Insurance Operations
Our insurance companies generally receive adequate cash flows from premium collections and investment income to meet their obligations. Life insurance, long-term care and supplemental health insurance and annuity liabilities are generally long-term in nature. Life and annuity policyholders may, however, withdraw funds or surrender their policies, subject to any applicable penalty provisions; there are generally no withdrawal or surrender benefits for long-term care insurance. We actively manage the relationship between the duration of our invested assets and the estimated duration of benefit payments arising from contract liabilities.
Three of the Company's insurance subsidiaries (Bankers Life, Washington National and Colonial Penn) are members of the FHLB. As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB. We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings. At June 30, 2023, the carrying value of the FHLB common stock was $79.7 million. As of June 30, 2023, collateralized borrowings from the FHLB totaled $1.8 billion and the proceeds were used to purchase matched variable rate fixed maturity securities. The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet. The borrowings are collateralized by investments with an estimated fair value of $2.3 billion at June 30, 2023, which are maintained in custodial accounts for the benefit of the FHLB.
State laws generally give state insurance regulatory agencies broad authority to protect policyholders in their jurisdictions. Regulators have used this authority in the past to restrict the ability of our insurance subsidiaries to pay any dividends or other amounts without prior approval. We cannot be assured that the regulators will not seek to assert greater supervision and control over our insurance subsidiaries' businesses and financial affairs.
Our estimated consolidated statutory RBC ratio was 386 percent at June 30, 2023, compared to 384 percent at December 31, 2022. In the first six months of 2023, the RBC ratio reflected our estimated consolidated statutory operating earnings of $76 million and insurance company dividends (net of capital contributions) of $74.7 million that were paid to the holding company. Our RBC ratio at June 30, 2023, exceeded our targeted RBC ratio of 375 percent and the minimum 350 percent that is reflected in our risk appetite statement that we share and discuss with rating agencies and insurance regulators. We believe that the 375 percent RBC ratio target continues to adequately support our financial strength and credit ratings.
In June 2023, we began a sale-leaseback program resulting in a $43 million reduction in non-admitted assets and a corresponding increase in total adjusted capital which favorably impacted our consolidated RBC ratio. Such sale-leaseback transactions are accounted for as operating leases pursuant to statutory accounting principles. Pursuant to GAAP, the sale-leaseback transactions do not meet the criteria for a sale. Accordingly, we account for these transactions as financing arrangements which are classified as other liabilities in our consolidated balance sheet.
Our insurance subsidiaries transfer exposure to certain risk to others through reinsurance arrangements. When we obtain reinsurance, we are still liable for those transferred risks in the event the reinsurer defaults on its obligations. The failure, insolvency, inability or unwillingness of one or more of the Company's reinsurers to perform in accordance with the terms of its reinsurance agreement could negatively impact our earnings or financial position and our consolidated statutory RBC ratio.
Financial Strength Ratings of our Insurance Subsidiaries
Financial strength ratings provided by AM Best Company ("AM Best"), Fitch Ratings ("Fitch"), Moody's Investor Services, Inc. ("Moody's") and S&P are the rating agency's opinions of the ability of our insurance subsidiaries to pay policyholder claims and obligations when due.
S&P most recently reviewed its "A-" financial strength ratings of our primary insurance subsidiaries on June 23, 2023. The outlook for these ratings is stable. S&P financial strength ratings range from "AAA" to "R" and some companies are not rated. An insurer rated "A", in S&P's opinion, has strong financial security characteristics, but is somewhat more likely to be affected by adverse business conditions than are insurers with higher ratings. Pluses and minuses show the relative standing within a category. S&P has twenty-one possible ratings. There are six ratings above the "A-" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating.
Moody's most recently reviewed its "A3" financial strength ratings of our primary insurance subsidiaries on May 12, 2023. The outlook for these ratings remains stable. Moody’s financial strength ratings range from "Aaa" to "C". These ratings may be supplemented with numbers "1", "2", or "3" to show relative standing within a category. In Moody's view, an insurer rated "A" offers good financial security, however, certain elements may be present which suggest a susceptibility to impairment sometime in the future. Moody's has twenty-one possible ratings. There are six ratings above the "A3" rating of our primary insurance subsidiaries and fourteen ratings that are below that rating.
On February 1, 2023, AM Best affirmed its "A" financial strength ratings of our primary insurance subsidiaries and the outlook for these ratings is stable. The "A" rating is assigned to companies that have an excellent ability, in AM Best's opinion, to meet their ongoing obligations to policyholders. AM Best ratings for the industry currently range from "A++ (Superior)" to "F (In Liquidation)" and some companies are not rated. An "A++" rating indicates a superior ability to meet ongoing obligations to policyholders. AM Best has sixteen possible ratings. There are two ratings above the "A" rating of our primary insurance subsidiaries and thirteen ratings that are below that rating.
On November 21, 2022, Fitch affirmed its "A-" financial strength ratings of our primary insurance subsidiaries and revised the outlook for these ratings to positive from stable. An insurer rated "A", in Fitch's opinion, indicates a low expectation of ceased or interrupted payments and indicates strong capacity to meet policyholder and contract obligations. This capacity may, nonetheless, be more vulnerable to changes in circumstances or in economic conditions than is the case for higher ratings. Fitch ratings for the industry range from "AAA Exceptionally Strong" to "C Distressed" and some companies are not rated. Pluses and minuses show the relative standing within a category. Fitch has nineteen possible ratings. There are six ratings above the "A-" rating of our primary insurance subsidiaries and twelve ratings that are below that rating.
Rating agencies have increased the frequency and scope of their credit reviews and requested additional information from the companies that they rate, including us. They may also adjust upward the capital and other requirements employed in their rating models for maintenance of certain ratings levels. We cannot predict what actions rating agencies may take, or what actions we may take in response. Accordingly, downgrades and outlook revisions related to us or the life insurance industry may occur in the future at any time and without notice by any rating agency. These could increase policy surrenders and withdrawals, adversely affect relationships with our distribution channels, reduce new sales, reduce our ability to borrow and increase our future borrowing costs.
Liquidity of the Holding Companies
Availability and Sources and Uses of Holding Company Liquidity; Limitations on Ability of Insurance Subsidiaries to Make Dividend and Surplus Debenture Interest Payments to the Holding Companies; Limitations on Holding Company Activities
At June 30, 2023, CNO, CDOC, Inc. ("CDOC", our wholly owned subsidiary and the immediate parent of Washington National and Conseco Life Insurance Company of Texas ("CLTX")) and our other non-insurance subsidiaries held $176 million of unrestricted cash and cash equivalents which was above our minimum target level of $150 million.
CNO and CDOC are holding companies with no business operations of their own; they depend on their operating subsidiaries for cash to make principal and interest payments on debt, and to pay administrative expenses and income taxes. CNO and CDOC receive cash from insurance subsidiaries, consisting of dividends and distributions, interest payments on surplus debentures and tax-sharing payments, as well as cash from non-insurance subsidiaries consisting of dividends, distributions, loans and advances. The principal non-insurance subsidiaries that provide cash to CNO and CDOC are 40|86 Advisors, Inc., which receives fees from the insurance subsidiaries for investment services, and CNO Services, LLC which receives fees from the insurance subsidiaries for providing administrative services. The agreements between our insurance subsidiaries and CNO Services, LLC and 40|86 Advisors, Inc., respectively, were previously approved by the domestic insurance regulator for each insurance company, and any payments thereunder do not require further regulatory approval.
The ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations and is based on the financial statements of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities, which differ from GAAP. These regulations generally permit dividends to be paid from statutory earned surplus of the insurance company without regulatory approval for any 12-month period in amounts equal to the greater of (or in some states, the lesser of): (i) statutory net gain from operations or net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. However, as each of the immediate insurance subsidiaries of CDOC has significant negative earned surplus, any dividend payments from the insurance subsidiaries require the prior approval of the director or commissioner of the applicable state insurance department. In the first six months of 2023, our insurance subsidiaries paid dividends to CDOC totaling $82.2 million. We expect to receive regulatory approval for future dividends from our subsidiaries, but there can be no assurance that such payments will be approved or that the financial condition of our insurance subsidiaries will not change, making future approvals less likely.
CDOC holds surplus debentures from CLTX with an aggregate principal amount of $749.6 million. Interest payments on those surplus debentures do not require additional approval provided the RBC ratio of CLTX exceeds 100 percent (but do require prior written notice to the Texas Department of Insurance). The estimated RBC ratio of CLTX was 339 percent at June 30, 2023. CDOC also holds a surplus debenture from Colonial Penn with a principal balance of $160.0 million. Interest payments on that surplus debenture require prior approval by the Pennsylvania Insurance Department. Dividends and other payments from our non-insurance subsidiaries, including 40|86 Advisors, Inc. and CNO Services, LLC, to CNO or CDOC do not require approval by any regulatory authority or other third party. However, insurance regulators may prohibit payments by our insurance subsidiaries to parent companies if they determine that such payments could be adverse to our policyholders or contractholders.
The insurance subsidiaries of CDOC receive funds to pay dividends primarily from: (i) the earnings of their direct businesses; (ii) tax sharing payments received from subsidiaries (if applicable); and (iii) with respect to CLTX, dividends received from subsidiaries. At June 30, 2023, the subsidiaries of CLTX had earned surplus (deficit) as summarized below (dollars in millions):
| Subsidiaries of CLTX | Earned surplus (deficit) | Additional information |
|---|---|---|
| Bankers Life | $367.0 | (a) |
| Colonial Penn | (488.4) | (b) |
(a) Bankers Life paid dividends of $55.0 million to CLTX in the first six months of 2023. Bankers Life may pay dividends without regulatory approval or prior notice for any 12-month period if such dividends are less than the greater of: (i) statutory net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. Dividends in excess of these levels require 30 days prior notice.
(b) The deficit is primarily due to transactions which occurred several years ago, including a tax planning transaction and the fee paid to recapture a block of business previously ceded to an unaffiliated insurer.
A significant deterioration in the financial condition, earnings or cash flow of the material subsidiaries of CNO or CDOC for any reason could hinder such subsidiaries' ability to pay cash dividends or other disbursements to CNO and/or CDOC, which, in turn, could limit CNO's ability to meet debt service requirements and satisfy other financial obligations. In addition, we may choose to retain capital in our insurance subsidiaries or to contribute additional capital to our insurance subsidiaries to maintain or strengthen their surplus or fund reinsurance transactions, and these decisions could limit the amount available at our top tier insurance subsidiaries to pay dividends to the holding companies. In the first six months of 2023, CDOC made a capital contribution of $7.5 million to CLTX.
At June 30, 2023, there are no amounts outstanding under our $250 million Revolving Credit Agreement and there are no scheduled repayments of our direct corporate obligations until May 2025.
Free cash flow is a measure of holding company liquidity and is calculated as: (i) dividends, management fees and surplus debenture interest payments received from our subsidiaries; plus (ii) earnings on corporate investments; less (iii) interest expense, corporate expenses and net tax payments. In the first six months of 2023, we generated $88 million of such free cash flow. The Company expects to deploy its free cash flow into investments to accelerate profitable growth, common stock dividends and share repurchases. The amount and timing of future share repurchases (if any) will be based on business and market conditions and other factors including, but not limited to, available free cash flow, the current price of our common stock and investment opportunities. In the first six months of 2023, we repurchased 2.0 million shares of common stock for $45.1 million under our securities repurchase program (including $0.9 million of repurchases settled in the third quarter of 2023). In May 2023, the Company's Board of Directors approved an additional $500.0 million to repurchase the Company's outstanding shares of common stock. The Company had remaining repurchase authority of $641.8 million as of June 30, 2023.
In the first six months of 2023, dividends declared on common stock totaled $33.8 million ($0.29 per common share). In May 2023, the Company increased its quarterly common stock dividend to $0.15 per share from $0.14 per share.
S&P most recently reviewed its "BBB-" rating on our senior unsecured debt on June 23, 2023. The outlook for these ratings is stable. In S&P's view, an obligation rated "BBB" exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitment on the obligation. Pluses and minuses show the relative standing within a category. S&P has a total of twenty-two possible ratings ranging from "AAA (Extremely Strong)" to "D (Payment Default)". There are nine ratings above CNO's "BBB-" rating and twelve ratings that are below its rating.
Moody's most recently reviewed its "Baa3" rating on our senior unsecured debt on May 12, 2023. The outlook for these ratings remains stable. In Moody's view, obligations rated "Baa" are subject to moderate credit risk and may possess certain speculative characteristics. A rating is supplemented with numerical modifiers "1", "2" or "3" to show the relative standing within a category. Moody's has a total of twenty-one possible ratings ranging from "Aaa" to "C". There are nine ratings above CNO's "Baa3" rating and eleven ratings that are below its rating.
On February 1, 2023, AM Best affirmed its "bbb" rating on our issuer credit and senior unsecured debt and the outlook for these ratings is stable. In AM Best's view, a company rated "bbb" has an adequate ability to meet the terms of its obligations; however, the issuer is more susceptible to changes in economic or other conditions. Pluses and minuses show the relative standing within a category. AM Best has a total of twenty-two possible ratings ranging from "aaa (Exceptional)" to "d (In default)". There are eight ratings above CNO's "bbb" rating and thirteen ratings that are below its rating.
On November 21, 2022, Fitch affirmed its "BBB-" rating on our senior unsecured debt. Fitch also affirmed CNO's long term issue default rating of "BBB" and revised the outlook for this rating to positive from stable. In Fitch's view, an obligation rated "BBB" indicates that expectations of default risk are currently low. The capacity for payment of financial commitments is considered adequate but adverse business or economic conditions are more likely to impair this capacity. Pluses and minuses show the relative standing within a category. Fitch has a total of twenty-one possible ratings ranging from "AAA" to "D". There are nine ratings above CNO's "BBB-" rating and eleven ratings that are below its rating.
We believe that the existing cash available to the holding company, the cash flows to be generated from operations and other transactions will be sufficient to allow us to meet our debt service obligations, pay corporate expenses and satisfy other financial obligations. However, our cash flow is affected by a variety of factors, many of which are outside of our control, including insurance regulatory issues, competition, financial markets and other general business conditions. We cannot provide assurance that we will possess sufficient income and liquidity to meet all of our debt service requirements and other holding company obligations.
INVESTMENTS
At June 30, 2023, the amortized cost, gross unrealized gains, gross unrealized losses, allowance for credit losses and estimated fair value of fixed maturities, available for sale, were as follows (dollars in millions):
| Investment grade (a): | Amortized cost | Gross unrealized gains | Gross unrealized losses | Allowance for credit losses | Estimated fair value |
|---|---|---|---|---|---|
| Corporate securities | $12,862.5 | $36.6 | $(1,627.5) | $(38.1) | $11,233.5 |
| United States Treasury securities and obligations of United States government corporations and agencies | 174.2 | — | (10.1) | — | 164.1 |
| States and political subdivisions | 2,804.6 | 27.6 | (387.5) | (.8) | 2,443.9 |
| Foreign governments | 93.9 | .6 | (10.2) | (.5) | 83.8 |
| Asset-backed securities | 1,365.7 | 1.0 | (118.1) | (.2) | 1,248.4 |
| Agency residential mortgage-backed securities | 351.4 | .4 | (3.0) | — | 348.8 |
| Non-agency residential mortgage-backed securities | 1,218.8 | 5.9 | (161.1) | — | 1,063.6 |
| Collateralized loan obligations | 961.1 | .9 | (28.1) | — | 933.9 |
| Commercial mortgage-backed securities | 2,471.1 | .3 | (266.8) | — | 2,204.6 |
| Total investment grade fixed maturities, available for sale | 22,303.3 | 73.3 | (2,612.4) | (39.6) | 19,724.6 |
| Below-investment grade (a) (b): | |||||
| Corporate securities | 573.8 | .9 | (42.6) | (26.3) | 505.8 |
| States and political subdivisions | 10.6 | — | (.7) | (.2) | 9.7 |
| Asset-backed securities | 119.8 | — | (18.7) | — | 101.1 |
| Non-agency residential mortgage-backed securities | 539.3 | 31.9 | (17.2) | — | 554.0 |
| Commercial mortgage-backed securities | 83.7 | — | (19.2) | — | 64.5 |
| Total below-investment grade fixed maturities, available for sale | 1,327.2 | 32.8 | (98.4) | (26.5) | 1,235.1 |
| Total fixed maturities, available for sale | $23,630.5 | $106.1 | $(2,710.8) | $(66.1) | $20,959.7 |
(a) Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations ("NRSROs") (Moody's, S&P or Fitch), or if not rated by such firms, the rating assigned by the National Association of Insurance Commissioners (the "NAIC"). NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch). NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch). References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.
(b) Certain structured securities rated below-investment grade by NRSROs may be assigned a NAIC 1 or NAIC 2 designation based on the cost basis of the security relative to estimated recoverable amounts as determined by the NAIC. Refer to the table below for a summary of our fixed maturity securities, available for sale, by NAIC designations.
The NAIC evaluates the fixed maturity investments of insurers for regulatory and capital assessment purposes and assigns securities to one of six credit quality categories called NAIC designations, which are used by insurers when preparing their annual statements based on statutory accounting principles. The NAIC designations are generally similar to the credit quality designations of the NRSROs for marketable fixed maturity securities, except for certain structured securities. However, certain structured securities rated below investment grade by the NRSROs can be assigned NAIC 1 or NAIC 2 designations depending on the cost basis of the holding relative to estimated recoverable amounts as determined by the NAIC. The following summarizes the NAIC designations and NRSRO equivalent ratings:
| NAIC Designation | NRSRO Equivalent Rating |
| 1 | AAA/AA/A |
| 2 | BBB |
| 3 | BB |
| 4 | B |
| 5 | CCC and lower |
| 6 | In or near default |
A summary of our fixed maturity securities, available for sale, by NAIC designations (or for fixed maturity securities held by non-regulated entities, based on NRSRO ratings) as of June 30, 2023 is as follows (dollars in millions):
| NAIC designation | Amortized cost | Estimated fair value | Percentage of total estimated fair value |
|---|---|---|---|
| 1 | $14,824.4 | $13,200.6 | 63.0% |
| 2 | 8,074.2 | 7,124.9 | 34.0 |
| Total NAIC 1 and 2 (investment grade) | 22,898.6 | 20,325.5 | 97.0 |
| 3 | 561.3 | 496.1 | 2.4 |
| 4 | 143.5 | 127.2 | .6 |
| 5 | 18.1 | 10.8 | — |
| 6 | 9.0 | .1 | — |
| Total NAIC 3, 4, 5 and 6 (below-investment grade) | 731.9 | 634.2 | 3.0 |
| Total | $23,630.5 | $20,959.7 | 100.0% |
102
Fixed Maturity Securities, Available for Sale
The following table summarizes the carrying values and gross unrealized losses of our fixed maturity securities, available for sale, by category as of June 30, 2023 (dollars in millions):
| Carrying value | Percent of fixed maturities | Gross unrealized losses | Percent of gross unrealized losses | |
|---|---|---|---|---|
| States and political subdivisions | $2,453.6 | 11.7% | $388.2 | 14.3% |
| Commercial mortgage-backed securities | 2,269.1 | 10.8 | 286.0 | 10.6 |
| Banks | 1,776.3 | 8.5 | 241.7 | 8.9 |
| Non-agency residential mortgage-backed securities | 1,617.6 | 7.7 | 178.3 | 6.6 |
| Asset-backed securities | 1,349.5 | 6.4 | 136.8 | 5.0 |
| Insurance | 1,136.7 | 5.4 | 193.7 | 7.2 |
| Utilities | 1,098.3 | 5.2 | 159.4 | 5.9 |
| Healthcare/pharmaceuticals | 1,045.4 | 5.0 | 187.8 | 6.9 |
| Brokerage | 940.1 | 4.5 | 138.3 | 5.1 |
| Collateralized loan obligations | 933.9 | 4.5 | 28.1 | 1.0 |
| Technology | 793.7 | 3.8 | 136.0 | 5.0 |
| Food/beverage | 665.1 | 3.2 | 72.3 | 2.7 |
| Energy | 507.0 | 2.4 | 46.4 | 1.7 |
| Cable/media | 458.3 | 2.2 | 75.0 | 2.8 |
| Real estate/REITs | 371.7 | 1.8 | 49.1 | 1.8 |
| Agency residential mortgage-backed securities | 348.8 | 1.7 | 3.0 | .1 |
| Transportation | 342.5 | 1.6 | 38.1 | 1.4 |
| Telecom | 331.6 | 1.6 | 28.0 | 1.0 |
| Capital goods | 273.3 | 1.3 | 31.9 | 1.2 |
| Chemicals | 262.5 | 1.2 | 35.8 | 1.3 |
| Other | 1,984.7 | 9.5 | 256.9 | 9.5 |
| Total fixed maturities, available for sale | $20,959.7 | 100.0% | $2,710.8 | 100.0% |
Below-Investment Grade Securities
At June 30, 2023, the amortized cost of the Company's below-investment grade fixed maturity securities, available for sale, was $1,327.2 million, or 5.6 percent of the Company's fixed maturity portfolio (or $731.9 million, or 3.1 percent, of the Company's fixed maturity portfolio measured on credit quality ratings assigned by the NAIC). The estimated fair value of the below-investment grade portfolio was $1,235.1 million, or 93 percent of the amortized cost.
Below-investment grade corporate debt securities typically have different characteristics than investment grade corporate debt securities. Based on historical performance, probability of default by the borrower is significantly greater for below-investment grade corporate debt securities and in many cases severity of loss is relatively greater as such securities are generally unsecured and often subordinated to other indebtedness of the issuer. Also, issuers of below-investment grade corporate debt securities frequently have higher levels of debt relative to investment-grade issuers, hence, all other things being equal, are generally more sensitive to adverse economic conditions. The Company attempts to reduce the overall risk related to its investment in below-investment grade securities, as in all investments, through careful credit analysis, strict investment policy guidelines, and diversification by issuer and/or guarantor and by industry.
Net Realized and Unrealized Investment Losses
During the first six months of 2023, we recognized $36.0 million of realized losses on sales of $388.8 million of fixed maturity securities, available for sale, including: (i) $29.8 million related to various corporate securities; (ii) $4.3 million related to commercial mortgage-backed securities; and (iii) $1.9 million related to various other investments. Securities are generally sold at a loss following unforeseen issuer-specific events or conditions or shifts in perceived relative values. These reasons include but are not limited to: (i) changes in the investment environment; (ii) expectation that the market value could deteriorate; (iii) our desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; (v) better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities; or (vi) changes in expected portfolio cash flows.
During the first six months of 2022, we recognized $56.9 million of realized losses on sales of $1,106.0 million of fixed maturity securities, available for sale, including: (i) $37.6 million related to various corporate securities; (ii) $10.2 million related to non-agency residential mortgage-backed securities; (iii) $4.2 million related to states and political subdivisions; and (iv) $4.9 million related to various other investments.
The following summarizes the investments sold at a loss during the first six months of 2023 which had been
continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period
indicated (dollars in millions):
| Number of issuers | At date of sale Amortized cost | Fair value | |
|---|---|---|---|
| Less than 6 months prior to sale | 2 | $40.6 | $20.1 |
| Greater than or equal to 6 months and less than 12 months prior to sale | 1 | 2.6 | .1 |
| Greater than 12 months prior to sale | 1 | .9 | .2 |
| $44.1 | $20.4 |
Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio. Significant losses could have a material adverse effect on our consolidated financial statements in future periods.
The following table sets forth the amortized cost and estimated fair value of those fixed maturities, available for sale, with unrealized losses at June 30, 2023, by contractual maturity. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. Structured securities frequently include provisions for periodic principal payments and permit periodic unscheduled payments.
(Dollars in millions)
| Amortized cost | Estimated fair value | |
|---|---|---|
| Due in one year or less | $110.0 | $107.8 |
| Due after one year through five years | 2,076.7 | 1,926.8 |
| Due after five years through ten years | 1,507.9 | 1,348.6 |
| Due after ten years | 11,131.8 | 9,298.7 |
| Subtotal | 14,826.4 | 12,681.9 |
| Structured securities | 6,436.6 | 5,804.2 |
| Total | $21,263.0 | $18,486.1 |
104
The following summarizes the investments in our portfolio rated below-investment grade not deemed to have credit losses which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of June 30, 2023 (dollars in millions):
| Number of issuers | Cost basis | Unrealized loss | Estimated fair value | |
|---|---|---|---|---|
| Less than 6 months | 12 | $74.9 | $(17.3) | $57.6 |
| Greater than or equal to 6 months and less than 12 months | 1 | 15.4 | (4.6) | 10.8 |
| Greater than 12 months | 3 | 20.1 | (7.2) | 12.9 |
| Total | $110.4 | $(29.1) | $81.3 |
105
The following table summarizes the gross unrealized losses of our fixed maturity securities, available for sale, by category and ratings category as of June 30, 2023 (dollars in millions):
| Investment grade AAA/AA/A | BBB | Below-investment grade BB | B+ and below | Total gross unrealized losses | |
|---|---|---|---|---|---|
| States and political subdivisions | $379.0 | $8.5 | $— | $.7 | $388.2 |
| Commercial mortgage-backed securities | 217.3 | 49.5 | 16.7 | 2.5 | 286.0 |
| Banks | 126.9 | 111.5 | 3.3 | — | 241.7 |
| Insurance | 94.5 | 95.5 | 3.3 | .4 | 193.7 |
| Healthcare/pharmaceuticals | 132.9 | 51.7 | 2.2 | 1.0 | 187.8 |
| Non-agency residential mortgage-backed securities | 103.2 | 57.9 | 1.4 | 15.8 | 178.3 |
| Utilities | 88.3 | 69.1 | 1.9 | .1 | 159.4 |
| Brokerage | 66.2 | 70.1 | 1.6 | .4 | 138.3 |
| Asset-backed securities | 46.3 | 71.8 | 17.8 | .9 | 136.8 |
| Technology | 82.2 | 49.1 | 4.4 | .3 | 136.0 |
| Cable/media | 9.1 | 60.3 | 2.8 | 2.8 | 75.0 |
| Food/beverage | 23.4 | 47.2 | 1.2 | .5 | 72.3 |
| Real estate/REITs | 26.9 | 21.5 | .7 | — | 49.1 |
| Energy | 6.8 | 39.4 | .2 | — | 46.4 |
| Transportation | 14.0 | 23.9 | — | .2 | 38.1 |
| Chemicals | 2.6 | 32.0 | .7 | .5 | 35.8 |
| Consumer products | 20.6 | 11.7 | 2.4 | .9 | 35.6 |
| Retail | 19.7 | 10.1 | 1.3 | 1.4 | 32.5 |
| Capital goods | 15.7 | 13.8 | 2.4 | — | 31.9 |
| Collateralized loan obligations | 24.7 | 3.4 | — | — | 28.1 |
| Telecom | .1 | 27.9 | — | — | 28.0 |
| Autos | 4.6 | 17.9 | 1.2 | .1 | 23.8 |
| Building materials | 4.6 | 16.8 | .6 | .2 | 22.2 |
| Aerospace/defense | 5.3 | 15.5 | — | .3 | 21.1 |
| Metals and mining | 4.8 | 9.5 | .6 | — | 14.9 |
| Paper | .7 | 10.6 | .1 | .5 | 11.9 |
| Foreign governments | 4.6 | 5.6 | — | — | 10.2 |
| United States Treasury securities and obligations of United States government corporations and agencies | 10.1 | — | — | — | 10.1 |
| Entertainment/hotels | 5.3 | 3.9 | .4 | — | 9.6 |
| Agency residential mortgage-backed securities | 3.0 | — | — | — | 3.0 |
| Business services | — | 1.0 | .6 | .3 | 1.9 |
| Other | 57.2 | 5.1 | .5 | .3 | 63.1 |
| Total fixed maturities, available for sale | $1,600.6 | $1,011.8 | $68.3 | $30.1 | $2,710.8 |
Our investment strategy is to maximize, over a sustained period and within acceptable parameters of quality and risk, investment income and total investment return through active strategic asset allocation and investment management. Accordingly, we may sell securities at a gain or a loss to enhance the projected total return of the portfolio as market opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.
Structured Securities
At June 30, 2023, fixed maturity investments included structured securities with an estimated fair value of $6.5 billion (or 31.1 percent of all fixed maturity securities). The yield characteristics of structured securities generally differ in some respects from those of traditional corporate fixed-income securities or government securities. For example, interest and principal payments on structured securities may occur more frequently, often monthly. In many instances, we are subject to variability in the amount and timing of principal and interest payments. For example, in many cases, partial prepayments may occur at the option of the issuer and prepayment rates are influenced by a number of factors that cannot be predicted with certainty, including: the relative sensitivity of prepayments on the underlying assets backing the security to changes in interest rates and asset values; the availability of alternative financing; a variety of economic, geographic and other factors; the timing, pace and proceeds of liquidations of defaulted collateral; and various security-specific structural considerations (for example, the repayment priority of a given security in a securitization structure). In addition, the total amount of payments for non-agency structured securities may be affected by changes to cumulative default rates or loss severities of the related collateral.
The amortized cost and estimated fair value of structured securities at June 30, 2023, summarized by type of security, were as follows (dollars in millions):
| Type | Amortized cost | Estimated fair value Amount | Percent of fixed maturities |
|---|---|---|---|
| Asset-backed securities | $1,485.5 | $1,349.5 | 6.4% |
| Agency residential mortgage-backed securities | 351.4 | 348.8 | 1.7 |
| Non-agency residential mortgage-backed securities | 1,758.1 | 1,617.6 | 7.7 |
| Collateralized loan obligations | 961.1 | 933.9 | 4.5 |
| Commercial mortgage-backed securities | 2,554.8 | 2,269.1 | 10.8 |
| Total structured securities | $7,110.9 | $6,518.9 | 31.1% |
Residential mortgage-backed securities ("RMBS") include transactions collateralized by agency-guaranteed and non-agency mortgage obligations. Non-agency RMBS investments are primarily categorized by underlying borrower credit quality: Prime, Alt-A, Non-Qualified Mortgage ("Non-QM"), and Subprime. Prime borrowers typically default with the lowest frequency, Alt-A and Non-QM default at higher rates, and Subprime borrowers default with the highest frequency. In addition to borrower credit categories, RMBS investments include Re-Performing Loan ("RPL") and Credit Risk Transfer ("CRT") transactions. RPL transactions include borrowers with prior difficulty meeting the original mortgage terms and were subsequently modified, resulting in a sustainable payback arrangement. CRT securities are collateralized by Government-Sponsored Enterprise ("GSE") conforming mortgages and Prime borrowers, but without an agency guarantee against default losses.
Commercial mortgage-backed securities ("CMBS") are secured by commercial real estate mortgages, generally income producing properties that are managed for profit. Property types include, but are not limited to, multi-family dwellings including apartments, retail centers, hotels, restaurants, hospitals, nursing homes, warehouses, and office buildings. While most CMBS have call protection features whereby underlying borrowers may not prepay their mortgages for stated periods of time without incurring prepayment penalties, recoveries on defaulted collateral may result in involuntary prepayments.
INVESTMENTS IN VARIABLE INTEREST ENTITIES
The following table provides supplemental information about the revenues and expenses of the VIEs which have been consolidated in accordance with authoritative guidance, after giving effect to the elimination of our investment in the VIEs and investment management fees earned by a subsidiary of the Company (dollars in millions):
| Revenues: | Three months ended June 30, 2023 | 2022 | Six months ended June 30, 2023 | 2022 |
|---|---|---|---|---|
| Net investment income – policyholder and other special-purpose portfolios | $22.0 | $12.8 | $44.4 | $23.6 |
| Fee revenue and other income | 1.2 | 1.1 | 2.5 | 2.5 |
| Total revenues | 23.2 | 13.9 | 46.9 | 26.1 |
| Expenses: | ||||
| Interest expense | 17.8 | 7.5 | 35.1 | 13.2 |
| Other operating expenses | .6 | .7 | 1.1 | 1.1 |
| Total expenses | 18.4 | 8.2 | 36.2 | 14.3 |
| Income before net investment losses and income taxes | 4.8 | 5.7 | 10.7 | 11.8 |
| Net investment losses | (3.4) | (7.0) | (4.0) | (10.2) |
| Income (loss) before income taxes | $1.4 | $(1.3) | $6.7 | $1.6 |
108
Supplemental Information on Investments Held by VIEs
The following table summarizes the carrying values and gross unrealized losses of the investments held by the VIEs by category as of June 30, 2023 (dollars in millions):
| Carrying value | Percent of fixed maturities | Gross unrealized losses | Percent of gross unrealized losses | |
|---|---|---|---|---|
| Cable/media | $116.8 | 12.3% | $3.9 | 12.7% |
| Technology | 115.1 | 12.1 | 7.6 | 24.5 |
| Healthcare/pharmaceuticals | 103.1 | 10.9 | 5.8 | 18.7 |
| Food/beverage | 66.7 | 7.0 | 2.0 | 6.4 |
| Brokerage | 59.7 | 6.3 | .7 | 2.3 |
| Building materials | 52.6 | 5.6 | .6 | 2.0 |
| Chemicals | 52.1 | 5.5 | .6 | 1.8 |
| Capital goods | 41.4 | 4.4 | 1.0 | 3.1 |
| Transportation | 41.4 | 4.4 | .3 | 1.1 |
| Paper | 41.2 | 4.3 | .6 | 2.0 |
| Utilities | 40.8 | 4.3 | 1.0 | 3.1 |
| Consumer products | 33.1 | 3.5 | 1.2 | 3.8 |
| Autos | 28.5 | 3.0 | .4 | 1.1 |
| Insurance | 27.7 | 2.9 | .2 | .8 |
| Business services | 26.5 | 2.8 | .3 | 1.1 |
| Aerospace/defense | 21.3 | 2.3 | 1.3 | 4.1 |
| Banks | 16.4 | 1.7 | .3 | .9 |
| Retail | 11.6 | 1.2 | .1 | .4 |
| Other | 52.2 | 5.5 | 3.2 | 10.1 |
| Total | $948.2 | 100.0% | $31.1 | 100.0% |
The following table sets forth the amortized cost and estimated fair value of those investments held by the VIEs with unrealized losses at June 30, 2023, by contractual maturity. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.
(Dollars in millions)
| Amortized cost | Estimated fair value | |
|---|---|---|
| Due in one year or less | $6.6 | $5.9 |
| Due after one year through five years | 667.1 | 637.3 |
| Due after five years through ten years | 143.4 | 138.4 |
| Total | $817.1 | $781.6 |
109
The following summarizes the investments held by the VIEs sold at a loss during the first six months of 2023 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):
| Number of issuers | At date of sale Amortized cost | Fair value | |
|---|---|---|---|
| Less than 6 months prior to sale | 1 | $1.7 | $1.2 |
| Greater than or equal to 6 months and less than 12 months prior to sale | 1 | 2.7 | .8 |
| Greater than 12 months prior to sale | 1 | 3.5 | 1.0 |
| $7.9 | $3.0 |
The following summarizes the investments held by the VIEs rated below-investment grade not deemed to have credit losses which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of June 30, 2023 (dollars in millions):
| Number of issuers | Cost basis | Unrealized loss | Estimated fair value | |
|---|---|---|---|---|
| Less than 6 months | 1 | $3.6 | $(1.1) | $2.5 |
| Greater than or equal to 6 months and less than 12 months | 1 | 2.9 | (.8) | 2.1 |
| Total | $6.5 | $(1.9) | $4.6 |
110
NEW ACCOUNTING STANDARDS
See "Recently Adopted Accounting Standards" in the notes to consolidated financial statements for a discussion of recently adopted accounting standards.
Market risk
As filed, 349 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our market risks, and the ways we manage them, are summarized in "Management's Discussion and Analysis of Financial Condition and Results of Operations", included in our Annual Report on Form 10-K for the year ended December 31, 2022. There have been no material changes in the first six months of 2023 to such risks or our management of such risks.
Controls and procedures
As filed, 1,430 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures. CNO's management, under the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of CNO's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, (the "Exchange Act")). Based on its evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2023, CNO's disclosure controls and procedures were effective to ensure that information required to be disclosed by CNO in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures are also designed to reasonably assure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes to Internal Control Over Financial Reporting. There were no changes in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the three months ended June 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 456 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
CNO and its businesses are subject to a number of risks including general business and financial risk. Any or all of such risks could have a material adverse effect on the business, financial condition or results of operations of CNO. Refer to "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022, for further discussion of such risk factors. There have been no material changes from such previously disclosed risk factors.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $1.02bn | us-gaap:Revenues |
| Revenue | 6 months2023-01-01 to 2023-06-30 | $2.03bn | us-gaap:Revenues |
| Operating income | 3 months2023-04-01 to 2023-06-30 | $81.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-06-30 | $157.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-04-01 to 2023-06-30 | $57.6m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-01-01 to 2023-06-30 | $112.3m | us-gaap:InterestExpense |
| Income tax | 3 months2023-04-01 to 2023-06-30 | $22.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-06-30 | $22.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-01 to 2023-06-30 | $73.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-06-30 | $72.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-01 to 2023-06-30 | $0.64 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-06-30 | $0.63 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | $0.64 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-06-30 | $0.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 115,650,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-06-30 | 116,189,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-06-30 | $223.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months2023-01-01 to 2023-06-30 | $34.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2023-01-01 to 2023-06-30 | $55.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2023-06-30 | $34.05bn | us-gaap:Assets |
| Total liabilities | At period end2023-06-30 | $32.06bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-06-30 | $2.00bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001224608-23-000046. Last ingested by Listed: Nov 14, 2026, 19:45 ET. Listed shows no prices and gives no investment advice.